Supernus Pharmaceuticals (SUPN)
Develops CNS medicines spanning ADHD, Parkinson’s disease, postpartum depression, and epilepsy.
$43.87
vs last close+0.12 (+0.27%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
$0.62
Revenue estimate
$218.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.75$0.42$0.91$1.01$0.92$0.59$0.54Pending
Estimate$0.46$0.38$0.47$0.82$0.28$0.28$0.42$0.62
Surprise+63.0%+10.5%+93.6%+23.2%+228.6%+110.7%+27.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$174.2M$149.8M$165.5M$192.1M$211.6M$207.7M$219.1MPending
Estimate$155.3M$147.9M$168.2M$194.7M$195.2M$192.9M$205.3M$218.3M
Surprise+12.2%+1.3%−1.6%−1.3%+8.4%+7.7%+6.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.09 | — | — |
| Sep 2027 | $0.93 | — | — |
| Jun 2027 | $0.70 | — | — |
| Mar 2027 | $0.50 | — | — |
| Dec 2026 | $0.70 | — | — |
| Nov 2026 | $0.62 | — | — |
| Aug 2026 | $0.42 | $0.54 | +27.8% |
| May 2026 | $0.28 | $0.59 | +110.7% |
| Feb 2026 | $0.28 | $0.92 | +228.6% |
| Nov 2025 | $0.82 | $1.01 | +23.2% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Jan 2017 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.09 | — | — | $277.2M | — | — | — |
| Sep 2027 | $0.93 | — | — | $261.6M | — | — | — |
| Jun 2027 | $0.70 | — | — | $254.4M | — | — | — |
| Mar 2027 | $0.50 | — | — | $235.6M | — | — | — |
| Dec 2026 | $0.70 | — | — | $234.9M | — | — | — |
| Nov 3, 2026 | $0.62 | — | — | $218.3M | — | — | — |
| Aug 3, 2026 | $0.42 | $0.54 | +27.8% | $205.3M | $219.1M | +6.7% | −6.0% |
| May 5, 2026 | $0.28 | $0.59 | +110.7% | $192.9M | $207.7M | +7.7% | +4.6% |
| Feb 24, 2026 | $0.28 | $0.92 | +228.6% | $195.2M | $211.6M | +8.4% | +5.7% |
| Nov 4, 2025 | $0.82 | $1.01 | +23.2% | $194.7M | $192.1M | −1.3% | −17.4% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 25, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 3, 2020 | |||||||
| Aug 18, 2020 | |||||||
| May 5, 2020 | |||||||
| Feb 25, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 26, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Feb 27, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 9, 2017 | |||||||
| Feb 28, 2017 | |||||||
| Jan 20, 2017 | |||||||
| Aug 2, 2016 | |||||||
| May 3, 2016 | |||||||
| Mar 2, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 4, 2015 |